Savara Inc. (SVRA)
NASDAQ: SVRA · Real-Time Price · USD
5.50
+0.12 (2.23%)
At close: Jun 18, 2026, 4:00 PM EDT
5.44
-0.06 (-1.09%)
After-hours: Jun 18, 2026, 6:31 PM EDT
Savara Market Cap
Savara has a market cap or net worth of $1.39 billion as of June 18, 2026. Its market cap has increased by 224.07% in one year.
Market Cap
1.39B
Enterprise Value
1.22B
1-Year Change
224.07%
Ranking
Category
Stock Price
$5.50
Market Cap Chart
Since April 28, 2017, Savara's market cap has increased from $132.70M to $1.39B, an increase of 951.09%. That is a compound annual growth rate of 29.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 1.13B | -8.13% |
| Dec 31, 2025 | 1.23B | 132.85% |
| Dec 31, 2024 | 526.90M | -17.17% |
| Dec 29, 2023 | 636.10M | 259.79% |
| Dec 30, 2022 | 176.80M | 25.21% |
| Dec 31, 2021 | 141.20M | 126.65% |
| Dec 31, 2020 | 62.30M | -66.25% |
| Dec 31, 2019 | 184.60M | -30.58% |
| Dec 31, 2018 | 265.90M | -41.25% |
| Dec 29, 2017 | 452.60M | 241.07% |
| Apr 28, 2017 | 132.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fortrea Holdings | 1.45B |
| SELLAS Life Sciences Group | 1.44B |
| Ardelyx | 1.44B |
| MoonLake Immunotherapeutics | 1.41B |
| Inhibrx Biosciences | 1.38B |
| Maze Therapeutics | 1.37B |
| Maravai LifeSciences Holdings | 1.35B |
| MapLight Therapeutics | 1.32B |